Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step

Journal of Virology

Volumn 84, Issue 18, 2010, Pages 9625-9631

  Widjaja, Ivy ^a   De Vries, Erik ^a   Tscherne, Donna M ^b   García Sastre, Adolfo ^b   Rottier, Peter J M ^a   De Haan, Cornelis A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PROTEASOME; UBIQUITIN; UBIQUITIN ACTIVATING ENZYME E1; UNCLASSIFIED DRUG; VIRUS RNA; ANTIVIRUS AGENT; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; ENZYME INHIBITOR; LEUPEPTIN; MACROLIDE; PROTEASOME INHIBITOR;

ARTICLE; CYTOPLASM; ENDOCYTOSIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; UBIQUITINATION; VIRUS ENTRY; VIRUS PARTICLE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; DOG; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DOGS; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS; LEUPEPTINS; MACROLIDES; PROTEASOME INHIBITORS; UBIQUITIN; VIRUS REPLICATION;

EID: 77956044811     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01048-10     Document Type: Article

References (35)

1. Andrejeva, J., D. F. Young, S. Goodbourn, and R. E. Randall. 2002. Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J. Virol. 76:2159-2167.
2. Bayer, N., D. Schober, E. Prchla, R. F. Murphy, D. Blaas, and R. Fuchs. 1998. Effect of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J. Virol. 72:9645-9655. (Pubitemid 28520828)
3. Chen, C., and X. Zhuang. 2008. Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc. Natl. Acad. Sci. U. S. A. 105:11790-11795.
4. Cross, K. J., L. M. Burleigh, and D. A. Steinhauer. 2001. Mechanisms of cell entry by influenza virus. Expert Rev. Mol. Med. 3:1-18.
5. Delboy, M. G., D. G. Roller, and A. V. Nicola. 2008. Cellular proteasome activity facilitates herpes simplex virus entry at a postpenetration step. J. Virol. 82:3381-3390.
6. Du, Z., L. Wei, A. Murti, S. R. Pfeffer, M. Fan, C. H. Yang, and L. M. Pfeffer. 2007. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J. Cell Biochem. 102:1087-1094.
7. Harty, R. N., M. E. Brown, J. P. McGettigan, G. Wang, H. R. Jayakar, J. M. Huibregtse, M. A. Whitt, and M. J. Schnell. 2001. Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. J. Virol. 75:10623-10629.
8. Henriet, S., G. Mercenne, S. Bernacchi, J. C. Paillart, and R. Marquet. 2009. Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors. Microbiol. Mol. Biol. Rev. 73:211-232.
9. Hui, E. K., and D. P. Nayak. 2001. Role of ATP in influenza virus budding. Virology 290:329-341.
10. Kandel, E. S. 2009. NFkappaB inhibition and more: a side-by-side comparison of the inhibitors of IKK and proteasome. Cell Cycle 8:1819-1820.
11. Kerscher, O., R. Felberbaum, and M. Hochstrasser. 2006. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22:159-180.
12. Khor, R., L. J. McElroy, and G. R. Whittaker. 2003. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4:857-868.
13. Konig, R., S. Stertz, Y. Zhou, A. Inoue, H. H. Hoffmann, S. Bhattacharyya, J. G. Alamares, D. M. Tscherne, M. B. Ortigoza, Y. Liang, Q. Gao, S. E. Andrews, S. Bandyopadhyay, P. De Jesus, B. P. Tu, L. Pache, C. Shih, A. Orth, G. Bonamy, L. Miraglia, T. Ideker, A. Garcia-Sastre, J. A. Young, P. Palese, M. L. Shaw, and S. K. Chanda. 2010. Human host factors required for influenza virus replication. Nature 463:813-817.
14. Kulka, R. G., B. Raboy, R. Schuster, H. A. Parag, G. Diamond, A. Ciechanover, and M. Marcus. 1988. A Chinese hamster cell cycle mutant arrested at G2 phase has a temperature-sensitive ubiquitin-activating enzyme, E1. J. Biol. Chem. 263:15726-15731.
15. Kumar, N., Z. T. Xin, Y. Liang, H. Ly, and Y. Liang. 2008. NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J. Virol. 82:9880-9889.
16. Lakadamyali, M., M. J. Rust, and X. Zhuang. 2004. Endocytosis of influenza viruses. Microbes Infect. 6:929-936.
17. Lutz, A., J. Dyall, P. D. Olivo, and A. Pekosz. 2005. Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication. J. Virol. Methods 126:13-20.
18. Martin, K., and A. Helenius. 1991. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65:232-244.
19. Muñoz-Jordan, J. L., G. G. Sanchez-Burgos, M. Laurent-Rolle, and A. Garcia-Sastre. 2003. Inhibition of interferon signaling by dengue virus. Proc. Natl. Acad. Sci. U. S. A. 100:14333-14338.
20. Nagata, K., A. Kawaguchi, and T. Naito. 2008. Host factors for replication and transcription of the influenza virus genome. Rev. Med. Virol. 18:247-260.
21. Nayak, D. P., E. K. Hui, and S. Barman. 2004. Assembly and budding of influenza virus. Virus Res. 106:147-165.
22. Nimmerjahn, F., D. Dudziak, U. Dirmeier, G. Hobom, A. Riedel, M. Schlee, L. M. Staudt, A. Rosenwald, U. Behrends, G. W. Bornkamm, and J. Mautner. 2004. Active NF-kappaB signalling is a prerequisite for influenza virus infection. J. Gen. Virol. 85:2347-2356.
23. Pleschka, S., R. Jaskunas, O. G. Engelhardt, T. Zurcher, P. Palese, and A. Garcia-Sastre. 1996. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:4188-4192.
24. Raaben, M., C. C. Posthuma, M. H. Verheije, E. G. te Lintelo, M. Kikkert, J. W. Drijfhout, E. J. Snijder, P. J. Rottier, and C. A. de Haan. 2010. The ubiquitin-proteasome system plays an important role during various stages in the coronavirus infection cycle. J. Virol. 84:7869-7879.
25. Ros, C., and C. Kempf. 2004. The ubiquitin-proteasome machinery is essential for nuclear translocation of incoming minute virus of mice. Virology 324:350-360. (Pubitemid 38797852)
26. Satheshkumar, P. S., L. C. Anton, P. Sanz, and B. Moss. 2009. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J. Virol. 83:2469-2479.
27. Si, X., G. Gao, J. Wong, Y. Wang, J. Zhang, and H. Luo. 2008. Ubiquitination is required for effective replication of coxsackievirus B3. PLoS One 3:e2585.
28. Skaug, B., X. Jiang, and Z. J. Chen. 2009. The role of ubiquitin in NF-kappaB regulatory pathways. Annu. Rev. Biochem. 78:769-796.
29. Stepnowski, P., A. C. Skladanowski, A. Ludwiczak, and E. Laczynska. 2004. Evaluating the cytotoxicity of ionic liquids using human cell line HeLa. Hum. Exp. Toxicol. 23:513-517.
30. Strous, G. J., P. van Kerkhof, R. Govers, A. Ciechanover, and A. L. Schwartz. 1996. The ubiquitin conjugation system is required for ligand-induced endocytosis and degradation of the growth hormone receptor. EMBO J. 15:3806-3812.
31. Tang, J., J. M. Colacino, S. H. Larsen, and W. Spitzer. 1990. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res. 13:313-325. (Pubitemid 20223545)
32. Tscherne, D. M., B. Manicassamy, and A. Garcia-Sastre. 2010. An enzymatic virus-like particle assay for sensitive detection of virus entry. J. Virol. Methods 163:336-343.
33. Ulane, C. M., and C. M. Horvath. 2002. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160-166.
34. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.
35. Yu, G. Y., and M. M. Lai. 2005. The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry. J. Virol. 79:644-648.